STN# 125612
Proper Name: Fibrinogen (Human)
Tradename: FIBRYGA
Manufacturer: OCTAPHARMA Pharmazeutika Produktionsges.m.b.H.
Indication:

FIBRYGA is a human fibrinogen concentrate indicated for:

  • fibrinogen supplementation in bleeding patients with acquired fibrinogen deficiency
  • treatment of acute bleeding episodes in patients with congenital fibrinogen deficiency, including afibrinogenemia and hypofibrinogenemia.

Limitations of Use:

  • FIBRYGA is not indicated for dysfibrinogenemia

Product Information

Supporting Documents

  • Content current as of:

    06/24/2025

Source

Clinical :: Oncology :: Nuclear :: Geriatric :: Regulatory :: Technology :: Consulting

"My passion is helping businesses, small and large, perform at their best." - Felicia Udoji-Eddings, Pharm.D.

Dr. Felicia Udoji-Eddings is the Founder and CEO of The Health Pals Company, a vertically integrated Healthcare System. As an experienced Clinical Pharmacy Leader, Pharmacy Consultant, Healthcare Executive, and Licensed Pharmacy Practitioner with deep backgrounds in Information Technology (IT), Scientific Research, and Business Management. Dr. Udoji-Eddings has a strong track record of exceptional performance in different business environments. A skilled Business Strategist, Dr. Udoji-Eddings has tackled complex problems and helped several organizations refocus their strategy in tough economic times. As a highly motivated and proactive individual, Felicia enjoys working with teams, in various capacities, to facilitate positive outcomes.